[1]
„CUT OFF VALUE OF PROCALCITONIN IN END STAGE RENAL DISEASE PATIENTS WITHOUT INFECTION“, Pak J Kidney Dis, sv. 5, izd. 02, str. 48–53, lip. 2021, doi: 10.53778/pjkd502144.